On Friday, Aptevo Therapeutics Inc (NASDAQ: APVO) was 7.81% up from the session before settling in for the closing price of $1.28. A 52-week range for APVO has been $1.04 – $298.00.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 80.96%. When this article was written, the company’s average yearly earnings per share was at 99.69%. With a float of $16.83 million, this company’s outstanding shares have now reached $16.85 million.
Aptevo Therapeutics Inc (APVO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aptevo Therapeutics Inc stocks. The insider ownership of Aptevo Therapeutics Inc is 0.10%, while institutional ownership is 7.19%. The most recent insider transaction that took place on Nov 10 ’25, was worth 20,134. In this transaction Director of this company bought 13,513 shares at a rate of $1.49, taking the stock ownership to the 13,514 shares.
Aptevo Therapeutics Inc (APVO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -178.8 earnings per share (EPS) during the time that was less than consensus figure (set at -155) by -23.8.
According to the Wall Street analysts, stocks earnings will be around 99.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 90.39% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
You can see what Aptevo Therapeutics Inc (APVO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.03. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -185.07, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
The latest stats from [Aptevo Therapeutics Inc, APVO] show that its last 5-days average volume of 0.59 million was inferior to 2.32 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 70.46%.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 15.04%, which indicates a significant decrease from 65.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0903 in the past 14 days, which was lower than the 0.1457 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4822, while its 200-day Moving Average is $12.7905. Now, the first resistance to watch is $1.4166. This is followed by the second major resistance level at $1.4533. The third major resistance level sits at $1.5165. If the price goes on to break the first support level at $1.3167, it is likely to go to the next support level at $1.2535. The third support level lies at $1.2168 if the price breaches the second support level.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
There are 16,850K outstanding shares of the company, which has a market capitalization of 23.25 million. As of now, sales total 0 K while income totals -24,130 K. Its latest quarter income was 0 K while its last quarter net income were -7,550 K.
